Catalyst Wire Dossier Catalyst Wire Dossier

CRLX-101

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRLX-101, covering 2017-11-14 to 2017-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer [Phase 1, Phase 2]

See pricing